Description

Methyl 7H-Pyrrolo[2,3-D]Pyrimidine-4-Carboxylate CAS NO 1095822-17-5 is a high-purity heterocyclic building block and pharmaceutical intermediate of significant commercial interest. This compound is valued for its role as a key precursor in the synthesis of complex molecules, particularly in medicinal chemistry and drug discovery. It is primarily sought after by research institutions, pharmaceutical R&D departments, and fine chemical manufacturers engaged in developing novel therapeutics, especially kinase inhibitors and other targeted agents.

Application

• Pharmaceutical Intermediate: A critical building block for the synthesis of kinase inhibitors and other small-molecule drug candidates.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies for novel therapeutic targets.
• Organic Synthesis: Serves as a versatile scaffold for constructing complex fused heterocyclic systems in academic and industrial laboratories.
• Biochemical Tool Development: Potential use in creating probes and labeled compounds for biological assay development and target validation.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations providing custom synthesis and process development services.
• Agrochemical Research: Exploration of its utility as an intermediate in the development of new active ingredients.

Basic Information

Product Name	Methyl 7H-Pyrrolo[2,3-D]Pyrimidine-4-Carboxylate
CAS No.	1095822-17-5
Molecular Formula	C8H7N3O2
Molecular Weight	177.16 g/mol
Synonyms	Methyl 7H-pyrrolo[2,3-d]pyrimidine-4-carboxylate; 4-Carbomethoxy-7H-pyrrolo[2,3-d]pyrimidine; Methyl 4-pyrrolo[2,3-d]pyrimidinecarboxylate; 7H-Pyrrolo[2,3-d]pyrimidine-4-carboxylic acid, methyl ester; 1095822-17-5; Methyl 7H-pyrrolo[2,3-d]pyrimidine-4-carboxylate (CAS 1095822-17-5)
EINECS	Contact for details

Quality Control

Our Methyl 7H-Pyrrolo[2,3-D]Pyrimidine-4-Carboxylate is manufactured under a strict quality management system to ensure batch-to-batch consistency and high purity. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We adhere to industry-standard analytical methods, including HPLC, NMR, and mass spectrometry, to guarantee the material meets the stringent requirements of pharmaceutical R&D and process chemistry.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The compound may be hygroscopic (moisture-sensitive); therefore, containers should be kept sealed under an inert atmosphere for long-term storage to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.